A centre of excellence for studying vaccine-preventable diseases has been launched in Bristol.
The centre is funded by coronavirus vaccine manufacturer Pfizer and is the second of a global network of sites to launch, and the first outside the US.
The Pfizer Centre of Excellence for Epidemiology of Vaccine-preventable Diseases, based at the University of Bristol, will undertake research to support the design, development and use of next-generation vaccines.
Health Secretary Matt Hancock visited the centre’s research laboratories on Tuesday (Dominic Lipinski/PA)
The pharmaceutical company said it had invested an initial £4.6 million into the centre to conduct surveillance studies in hospitals and the community to “identify and measure the burden of specific vaccine-preventable infectious diseases affecting adults, including the elderly, as well as children”.
(301) 975-4935
Wastewater surveillance is a promising approach to monitor biological and chemical contaminants on a community level, and has recently been shown effective for the early detection of SARS-CoV-2 outbreaks. While much has been learned in the past year, much work remains to establish an enduring capability for wastewater surveillance poised to address new targets as they emerge. The goal of this workshop is to identify and prioritize standards needs and technology/measurement gaps and propose a potential path forward to develop standards that help enable a robust, comparable wastewater surveillance capability. Topics to be discussed include lessons learned during the COVID-19 pandemic response, the state of the art in measurement science and technology for the entire wastewater surveillance workflow, and challenges in achieving comparable wastewater surveillance results across locations. Stakeholder input will inform future standards development activities, inc
Pfizer-funded vaccine research centre launches in England
The group will undertake research to support the design, development and use of next-generation vaccines
Updated
The video will auto-play soon8Cancel
Play now
There are always big stories on WalesOnline - don t miss any with our daily emailInvalid EmailSomething went wrong, please try again later.
Sign me up now
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
A centre of excellence (COE) for studying vaccine-preventable diseases has been launched in the UK.
Pfizer-funded vaccine research centre launches in UK
The group will undertake research to support the design, development and use of next-generation vaccines
Updated
The video will auto-play soon8Cancel
Play now
Subscribe today to get the latest headlines straight to your inbox with our free email updatesInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
A centre of excellence (COE) for studying vaccine-preventable diseases has been launched in the UK.
Louisville businessman investing in new NBA effort - Louisville Business First bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.